The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Cardiovascular Phenotype in Turner Syndrome—Integrating Cardiology, Genetics, and Endocrinology
Abstract
Cardiovascular disease is emerging as a cardinal trait of Turner syndrome, being responsible for half of the 3-fold excess mortality. Turner syndrome has been proposed as an independent risk marker for cardiovascular disease that manifests as congenital heart disease, aortic dilation and dissection, valvular heart disease, hypertension, thromboembolism, myocardial infarction, and stroke. Risk stratification is unfortunately not straightforward because risk markers derived from the general population inadequately identify the subset of females with Turner syndrome who will suffer events. A high prevalence of endocrine disorders adds to the complexity, exacerbating cardiovascular prognosis. Mounting knowledge about the prevalence and interplay of cardiovascular and endocrine disease in Turner syndrome is paralleled by improved understanding of the genetics of the X-chromosome in both normal health and disease. At present in Turner syndrome, this is most advanced for the SHOX gene, which partly explains the growth deficit. This review provides an up-to-date condensation of current state-of-the-art knowledge in Turner syndrome, the main focus being cardiovascular morbidity and mortality. The aim is to provide insight into pathogenesis of Turner syndrome with perspectives to advances in the understanding of genetics of the X-chromosome. The review also incorporates important endocrine features, in order to comprehensively explain the cardiovascular phenotype and to highlight how raised attention to endocrinology and genetics is important in the identification and modification of cardiovascular risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
The incidence of congenital heart disease.
Hoffman, J. I. E., & Kaplan, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01886-7 · Cited by 6,099
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978
WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE
Barker, D. J. P., Osmond, C., Winter, P. D., Margetts, B., & Simmonds, S. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90710-1 · Cited by 3,574
O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“stroke of any cause (188) is increased from a young age in”
BackgroundLorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328333146d · Cited by 1,643
Klein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Common mechanisms of nerve and blood vessel wiring
Carmeliet, P., & Tessier-Lavigne, M. (2005) · Nature · doi:10.1038/nature03875 · Cited by 1,085
Siu, S. C., & Silversides, C. K. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.068 · Cited by 1,028
Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group
Bondy, C. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1374 · Cited by 1,005
Sex-specific genetic architecture of human disease
Ober, C., Loisel, D. A., & Gilad, Y. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2415 · Cited by 787
Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function
Skuse, D. H., James, R. S., Bishop, D. V. M., Coppin, B., Dalton, P., Aamodt-Leeper, G., Bacarese-Hamilton, M., Creswell, C., McGurk, R., & Jacobs, P. A. (1997) · Nature · doi:10.1038/42706 · Cited by 747
Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J., & Jørgensen, T. (2002) · Circulation · doi:10.1161/01.cir.0000027563.44593.cc · Cited by 640
Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P.-Y. (2008) · BMJ · doi:10.1136/bmj.39555.441944.be · Cited by 569
Gravholt, C. H., Juul, S., Naeraa, R. W., & Hansen, J. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00237-0 · Cited by 548 · cited 9×
“pertension are substantial (3, 4), and there is an unfortu-”
BackgroundInfluentialEstrogen Receptors and the Metabolic Network
Barros, R. P. A., & Gustafsson, J.-Å. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.005 · Cited by 458
Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)
Singh, J. P., Larson, M. G., O’Donnell, C. J., Wilson, P. F., Tsuji, H., Lloyd-Jones, D. M., & Levy, D. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00920-6 · Cited by 439
Mortality in women with Turner syndrome in Great Britain: a national cohort study
Schoemaker, M. J., Swerdlow, A. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1049 · Cited by 360 · cited 8×
“Increased morbidity and mortality are cardinal traits in TS (1, 3, 4, 10).”
BackgroundInfluentialMajor Vascular Anomalies in Turner Syndrome: Prevalence and Magnetic Resonance Angiographic Features
Ho, V. B., Bakalov, V. K., Cooley, M., Van, P. L., Hood, M. N., Burklow, T. R., & Bondy, C. A. (2004) · Circulation · doi:10.1161/01.cir.0000142290.35842.b0 · Cited by 316
(2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2187 · Cited by 256
Løkkegaard, E., Jovanovic, Z., Heitmann, B. L., Keiding, N., Ottesen, B., & Pedersen, A. T. (2006) · Maturitas · doi:10.1016/j.maturitas.2005.04.009 · Cited by 243
Growth hormone plus childhood low-dose estrogen in Turner's syndrome
Ross, J. L., Quigley, C. A., Cao, D., Feuillan, P., Kowal, K., Chipman, J. J., & Cutler, G. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005669 · Cited by 212
Langrish, J. P., Mills, N. L., Bath, L. E., Warner, P., Webb, D. J., Kelnar, C. J., Critchley, H. O. D., Newby, D. E., & Wallace, W. H. B. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.126516 · Cited by 207
Karnis, M. F., Zimon, A. E., Lalwani, S. I., Timmreck, L. S., Klipstein, S., & Reindollar, R. H. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00974-9 · Cited by 206
Gravholt, C. H., Naeraa, R. W., Nyholm, B., Gerdes, L. U., Christiansen, E., Schmitz, O., & Christiansen, J. S. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1062 · Cited by 204
Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner syndrome?
Clark, E. B. (1984) · Teratology · doi:10.1002/tera.1420290305 · Cited by 160
Hadnott, T. N., Gould, H. N., Gharib, A. M., & Bondy, C. A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.085 · Cited by 153
Ostberg, J. E., Brookes, J. A. S., McCarthy, C., Halcox, J., & Conway, G. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1090 · Cited by 146
Vascular involvement of the liver in Turner's syndrome
Roulot, D., Degott, C., Chazouillères, O., Oberti, F., Calès, P., Carbonell, N., Benferhat, S., Bresson-Hadni, S., & Valla, D. (2004) · Hepatology · doi:10.1002/hep.20026 · Cited by 143
Chevalier, N., Letur, H., Lelannou, D., Ohl, J., Cornet, D., Chalas-Boissonnas, C., Frydman, R., Catteau-Jonard, S., Greck-Chassain, T., Papaxanthos-Roche, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0925 · Cited by 142
Impaired insulin secretion in the Turner metabolic syndrome
Bakalov, V. K., Cooley, M. M., Quon, M. J., Luo, M. L., Yanovski, J. A., Nelson, L. M., Sullivan, G., & Bondy, C. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0122 · Cited by 137
Kim, H. K., Gottliebson, W., Hor, K., Backeljauw, P., Gutmark-Little, I., Salisbury, S. R., Racadio, J. M., Helton-Skally, K., & Fleck, R. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.4973 · Cited by 126
Renal malformations in patients with Turner syndrome: imaging in 141 patients
Lippe, B., Geffner, M. E., Dietrich, R. B., Boechat, M. I., & Kangarloo, H. (1988) · PEDIATRICS · doi:10.1542/peds.82.6.852 · Cited by 122 · cited 1×
“Renovascular (238) and endocrine hypertension (181, 251) are rare in TS, although various renal malformations occur in a third of all TS (252).”
BackgroundFreriks, K., Timmermans, J., Beerendonk, C. C. M., Verhaak, C. M., Netea-Maier, R. T., Otten, B. J., Braat, D. D. M., Smeets, D. F. C. M., Kunst, D. H. P. M., Hermus, A. R. M. M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0346 · Cited by 120 · cited 2×
“Additionally, clinical assessment is poor even in diagnosed individuals (5), although multidisciplinary practice may improve this (6).”
BackgroundX-chromosome gene dosage and the risk of diabetes in Turner syndrome
Bakalov, V. K., Cheng, C., Zhou, J., & Bondy, C. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0384 · Cited by 118
Long-term safety of recombinant human growth hormone in Turner syndrome
Bolar, K., Hoffman, A. R., Maneatis, T., & Lippe, B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1723 · Cited by 116
Landin-Wilhelmsen, K., Bryman, I., & Wilhelmsen, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7818 · Cited by 113
Hormone replacement therapy may improve hepatic function in women with Turner's syndrome
Elsheikh, M., Hodgson, H. J. F., Wass, J. A. H., & Conway, G. S. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01321.x · Cited by 109
Turner's syndrome in fetal life
Surerus, E., Huggon, I. C., & Allan, L. D. (2003) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.151 · Cited by 106
Mortensen, K. H., Hjerrild, B. E., Stochholm, K., Andersen, N. H., Sørensen, K. E., Lundorf, E., Hørlyck, A., Pedersen, E. M., Christiansen, J. S., & Gravholt, C. H. (2011) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-13-24 · Cited by 99
Efficacy and safety of oxandrolone in growth hormone-treated girls with Turner syndrome
Menke, L. A., Sas, T. C. J., de Muinck Keizer-Schrama, S. M. P. F., Zandwijken, G. R. J., de Ridder, M. A. J., Odink, R. J., Jansen, M., Delemarre-van de Waal, H. A., Stokvis-Brantsma, W. H., Waelkens, J. J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1821 · Cited by 94
Mortensen, K. H., Hjerrild, B. E., Andersen, N. H., Sørensen, K. E., Hørlyck, A., Pedersen, E. M., Lundorf, E., Christiansen, J. S., & Gravholt, C. H. (2010) · Cardiology in the Young · doi:10.1017/s1047951110000041 · Cited by 93
Self-citationNocturnal hypertension and impaired sympathovagal tone in Turner syndrome
Gravholt, C. H., Hansen, K. W., Erlandsen, M., Ebbehøj, E., & Christiansen, J. S. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000200509.17947.0f · Cited by 90
Self-citationTaboada, M., Santen, R., Lima, J., Hossain, J., Singh, R., Klein, K. O., & Mauras, N. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1449 · Cited by 82
Structural and functional abnormalities of large arteries in the Turner syndrome
Baguet, J.-P., Douchin, S., Pierre, H., Rossignol, A.-M., Bost, M., & Mallion, J.-M. (2005) · Heart · doi:10.1136/hrt.2004.048371 · Cited by 72
Androgen replacement therapy in Turner syndrome: a pilot study
Zuckerman-Levin, N., Frolova-Bishara, T., Militianu, D., Levin, M., Aharon-Peretz, J., & Hochberg, Z. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0514 · Cited by 69
Bondy, C. A., Ceniceros, I., Van, P. L., Bakalov, V. K., & Rosing, D. R. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0776 · Cited by 59 · cited 4×
“These findings may help to explain the prolonged QT interval seen in TS (55).”
BackgroundInfluentialProlongation of the cardiac QTc interval in Turner syndrome
Bondy, C. A., Van, P. L., Bakalov, V. K., Sachdev, V., Malone, C. A., Ho, V. B., & Rosing, D. R. (2006) · Medicine · doi:10.1097/01.md.0000205629.16302.bc · Cited by 55
Repeated spontaneous pregnancies in 45 X Turner syndrome
Mortensen, K. H., Rohde, M. D., Uldbjerg, N., & Gravholt, C. H. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181cb5b2a · Cited by 52
Self-citationAortic dimensions in girls and young women with Turner syndrome: a magnetic resonance imaging study
Cleemann, L., Mortensen, K. H., Holm, K., Smedegaard, H., Skouby, S. O., Wieslander, S. B., Leffers, A.-M., Leth-Espensen, P., Pedersen, E. M., & Gravholt, C. H. (2010) · Pediatric Cardiology · doi:10.1007/s00246-009-9626-8 · Cited by 49
Self-citationDelayed β-cell response and glucose intolerance in young women with Turner syndrome
Hjerrild, B. E., Holst, J. J., Juhl, C. B., Christiansen, J. S., Schmitz, O., & Gravholt, C. H. (2011) · BMC Endocrine Disorders · doi:10.1186/1472-6823-11-6 · Cited by 45
Self-citationAre young women with Turner syndrome at greater risk of coronary artery disease?
Kozlowska-Wojciechowska, M., Jez, W., Zdrojewski, T., & Chwojnicki, K. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000216545.99807.fd · Cited by 33 · cited 2×
“• Hypertension (81) • Insulin resistance (227) and overt diabetes (1) • Dyslipidemia (228) • Obesity (229) • Estrogen deficiency (229) • GH deficiency (229) • Hypercoagulable clotting system (201)”
BackgroundLanzarini, L., Larizza, D., Prete, G., Calcaterra, V., Meloni, G., Sammarchi, L., & Klersy, C. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000269716.33435.d3 · Cited by 30
Left ventricular thickness is increased in nonhypertensive Turner's syndrome
Sozen, A. B., Cefle, K., Kudat, H., Ozturk, S., Oflaz, H., Akkaya, V., Palanduz, S., Demirel, S., Ozcan, M., Goren, T., et al. (2009) · Echocardiography · doi:10.1111/j.1540-8175.2009.00902.x · Cited by 19
Cited by
Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0430 · Cited by 1,101
Self-citationTurner syndrome: mechanisms and management
Gravholt, C. H., Viuff, M. H., Brun, S., Stochholm, K., & Andersen, N. H. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0224-4 · Cited by 347
Self-citationKlinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology
Gravholt, C. H., Chang, S., Wallentin, M., Fedder, J., Moore, P., & Skakkebæk, A. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00212 · Cited by 328
Self-citationClinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Self-citationThe Turner syndrome life course project: karyotype-phenotype analyses across the lifespan
Cameron‐ Pimblett, A., La Rosa, C., King, T. F. J., Davies, M. C., & Conway, G. S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13394 · Cited by 161
Metadata
- Authors
- Mortensen, K. H., Andersen, N. H., & Gravholt, C. H.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2012-06-15
- Volume
- 33
- Issue
- 5
- Pages
- 677-714
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2131778826
- Cited by
- 218
- References
- 56
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.